A common variant in DRD3 gene is associated with risperidone-induced extrapyramidal symptoms.
about
Analysis of pharmacogenomic variants associated with population differentiationThe promise and reality of pharmacogenetics in psychiatryPharmacogenetics of antipsychotic-induced side effectsBrief report: the dopamine-3-receptor gene (DRD3) is associated with specific repetitive behavior in autism spectrum disorder (ASD).Association of common genetic variants with risperidone adverse events in a Spanish schizophrenic population.Pharmacogenetics of response to antipsychotics in patients with schizophrenia.Toward understanding genetic risk for differential antipsychotic response in individuals with schizophrenia.Strengths and weaknesses of pharmacogenetic studies of antipsychotic drugs: the potential value of the PEPs study.Pharmacogenetics of clinical response to risperidone.Individualizing clozapine and risperidone treatment for schizophrenia patients.Applicability of gene expression and systems biology to develop pharmacogenetic predictors; antipsychotic-induced extrapyramidal symptoms as an example.Network analysis of gene expression in mice provides new evidence of involvement of the mTOR pathway in antipsychotic-induced extrapyramidal symptoms.Pharmacogenetic study of antipsychotic induced acute extrapyramidal symptoms in a first episode psychosis cohort: role of dopamine, serotonin and glutamate candidate genes.Neurotransmitter systems and neurotrophic factors in autism: association study of 37 genes suggests involvement of DDC.Network analysis of gene expression in peripheral blood identifies mTOR and NF-κB pathways involved in antipsychotic-induced extrapyramidal symptoms.
P2860
Q28544983-D259DC3C-6EC0-4033-A997-BF8D6DD2187EQ35226451-610B50E7-AB84-4730-9B5D-7C9CFA2E3005Q35237129-7391BAE6-6B1B-42DC-A06B-5B21CD600AB6Q35884311-F7230966-3756-4C52-88A5-54A3498F7A8AQ36747019-F5183434-5E6F-45FE-A9F1-626C7FDC246EQ37952823-4050AC1A-1B5B-4F04-ADD2-A016AA0AD31BQ37960512-2EB9A558-0E89-4AAC-91D4-BF0BDDE184D3Q38061501-E2C26B6E-F3B2-47B4-9515-198E1B785CECQ38074712-1F9DC16F-8C40-4F0B-BFEE-AA729D2F475DQ38170458-F7EBA6A3-9930-4130-9AA4-FEB2EC7A6EDCQ38630075-A33B2821-5629-41E3-9B5F-F09178A2682EQ38990216-E8A76C55-D51C-42BA-8BD3-4911C2278D5EQ48006592-912C11D7-032C-4A7C-A3A5-8AC49F07E463Q48625126-B8544FEE-76D6-4E7F-8DEE-B9B30DDFC045Q50452964-3DFEB410-464F-4BCD-8A4A-669A0D61FEB8
P2860
A common variant in DRD3 gene is associated with risperidone-induced extrapyramidal symptoms.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
A common variant in DRD3 gene ...... duced extrapyramidal symptoms.
@en
A common variant in DRD3 gene ...... duced extrapyramidal symptoms.
@nl
type
label
A common variant in DRD3 gene ...... duced extrapyramidal symptoms.
@en
A common variant in DRD3 gene ...... duced extrapyramidal symptoms.
@nl
prefLabel
A common variant in DRD3 gene ...... duced extrapyramidal symptoms.
@en
A common variant in DRD3 gene ...... duced extrapyramidal symptoms.
@nl
P2093
P2860
P50
P356
P1476
A common variant in DRD3 gene ...... duced extrapyramidal symptoms.
@en
P2093
P2860
P2888
P304
P356
10.1038/TPJ.2009.26
P577
2009-06-09T00:00:00Z
P5875
P6179
1041249978